HUBUNGAN DURASI MENDERITA HIPERTENSI DENGAN KEJADIAN RETINOPATI HIPERTENSI DI RSUD DR. A. DADI TJOKRODIPO BANDAR LAMPUNG PERIODE 2017-2020

Jyoti Krisna Murti; Rani Himayani; Hanna Mutiara; Muhammad Yusran

Authors

Jyoti Krisna Murti Fakultas Kedokteran Universitas Lampung
Rani Himayani Bagian Ilmu Kesehatan Mata, Fakultas Kedokteran, Universitas Lampung
Hanna Mutiara
Muhammad Yusran

Keywords:

Duration of Hypertension, Hypertensive Retinopathy, RSUD Dr. A. Dadi Tjokrodipo Bandar Lampung

Abstract

Hypertension in Indonesia increase every year until in 2018 reached 34.1%. Long duration hypertension cause organ damage, hypertensive retinopathy is one of them. Hypertensive retinopathy shows changes in retinal vascularity such as narrowing and sclerosis in response to increased pressure of blood. The purpose of this study was to determine the relationship between the duration of hypertension and event of hypertensive retinopathy in RSUD Dr. A. Dadi Tjokrodipo Bandar Lampung Period 2017-2020. This study used an observational analysis research method with a cross sectional approach. The research subjects consisted of 168 samples. Sampling method using total sampling. Data on the duration of hypertension and the event of hypertensive retinopathy were taken from medical records. The analytical test used is the chi-square test. This study that of the 168 respondents with hypertension, 53.0% were aged 40-60 years. Patients with hypertension are male as much as 65.5%. Patients with hypertension degree 2 as much as 71%. Based on the duration of suffering from hypertension, the most common duration was 61.3%. As many as 72.6% of hypertensive patients did not experience hypertensive retinopathy, while 27.4% had hypertensive retinopathy. The results of chi-Square analysis showed that there was a significant relationship between the duration of suffering from hypertension and the incidence of hypertensive retinopathy (p = 0.000). There is a significant relationship between the duration hypertension and event of hypertensive retinopathy in RSUD Dr. A. Dadi Tjokrodipo Bandar Lampung period 2017-2020

References

Albert D, Scheef E, Wang S, Mehraein F, Darjatmoko S. 2017. Calcitriol Is a Potent Inhibitor of Retinal Neovascularization. Investigative Opthalmology & Visual Science. 48(5):2327.

Chobanion A, Bakris GL, Black HR. 2017. The seventh report of the joint national committee on : prevention, detection, evaluation, and treatment of high blood pressure. NIH Publication.

Kemenkes RI. 2019. Faktor risiko penyebab hipertensi. Jakarta: Kementerian Kesehatan Republik Indonesia.

Reins R, McDermott A. 2018. Vitamin D: Implications for ocular disease and therapeutic potential. Experimental Eye Research.134:101- 110.

Balitbangkes. 2018. Riset Kesehatan Dasar (Riskesdas) 2018. Kementerian RI.

Setyowati S. 2015. Faktor-faktor yang berperan terhadap kejadian retinopati hipertensi pada pasien hipertensi esensial non diabetik. Semarang : Universitas Diponegoro.

Eni. 2019. Hubungan usia dan jenis kelamin beresiko dengan kejadian hipertensi di klinik x kota Tangerang. 25(5): 22-32

Putu N. 2016. Hipertensi dan retinopati hipertensi. 2(1): 48–56.

Erden S, Bicakci E. 2018. Hypertensive Retinopathy: Risk Factors, and Comorbidities. Clinical and Experimental Hypertension. 34(6): 397-401.

Rahman H. 2018. Profil Retinopathy Hipertensi di Rumah Sakit DR. M Djamil Padang.

Besharati MR, Rastegar A, Shoja MR, Maybodi ME. 2019. Prevalence of retinopathy in hypertensive patients. Saudi Med J.27(II):1725-8. 16.

Wong TY, Mitchell P. 2018. Hypertensive retinopathy. New England Journal of Medicine. 3: 10-17.

Zhang Y, Zhao L, Li H, dan Wang Y. 2018. Risk factor for hypertensive retinopathy in a Chinese population with Hypertension: The Beijing Eye Study. Experimental and Theurapeutic Medicine. 17: 453-458.

Kabedi NN, Mwanza JC, Lepira FB. 2014. Hypertensive retinopathy and its association with cardiovascular, renal and cerebrovascular morbidity in Congolese patients. Cardivaskular Journal of Africa. 25(5): 22-32.

Mondal RN, Matin MA, Rani M. 2019. Prevalence and risk factors of hypertensive retinopathy in hipertensive patients. J Hypertens. 6(2): 1-5.